$UTHR
AI 分析生成於 May 11, 2026
AI Score
Buy$UTHR
United Therapeutics
$UTHRNASDAQHealthcareLarge-Cap
United Therapeutics develops therapies for pulmonary arterial hypertension and organ transplantation.
Market Cap
$14.0B
Revenue (TTM)
$2.8B
+12.0%
Net Income (TTM)
$1.0B
+15.0%
EPS (TTM)
$22.00
P/E Ratio
12.0
Dividend Yield
0.0%
52-Week Range
$220-$350
Beta
0.52
Dimension Scores
Fundamental
78Technical
72Sentiment
74Risk / Reward
76Momentum
70Financial Health
Profitability
83strong
Growth
73moderate
Liquidity
84strong
Solvency
80strong
Efficiency
76strong
Valuation, technical analysis, investment thesis, risk assessment and more for $UTHR
Free · No credit card required
免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。